During the Geneva Association’s media call on Global Risks & Insurance, Darren Pain, Director of Cyber, highlighted his expectation for continued growth in the cyber insurance-linked securities (ILS) market, though he noted this growth is likely to be gradual due to ongoing challenges.The cyber ILS market has developed rapidly, with 2023 marking a pivotal year … Read more
By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported third quarter results on November 6th, 2024. Revenues totaled $8.2 million and the burn trial has completed enrollment while the emergency department burn enrollment continues. The company also received additional funding from the Medical Technology Enterprise Consortium (MTEC) to … Read more
Given where the retrocession market is positioned and the fact retro strategies are now less exposed to lower industry-loss level events, we could see more capital coming to support that segment, but Gregory Roberts, CUO of Conduit Re does not expect capital providers risk appetites to change.Speaking during a media call today, after Bermuda-based reinsurance … Read more
The commercial auto insurance line has struggled to achieve underwriting profitability for years, even before the inflationary conditions that have been affecting property/casualty lines more recently. This trend has been accompanied by steady growth in net written premiums (NWP). This weakness in underwriting profitability has been driven by several causes, according to a new Triple-I … Read more
By M. Marin NASDAQ:WINT Lead Drug Candidates, New Phase 2b Clinical Trial Data, Multiple Programs Focus on Unmet Needs In Cardiogenic Shock & AHF Pennsylvania-based Windtree Therapeutics, Inc. (NASDAQ:WINT) is a biopharmaceutical company developing therapies for a range of cardiovascular and oncology treatments characterized by significant unmet need. The company’s lead indication area is cardiogenic … Read more
